Malignant Mesothelioma - Epithelioid Type

Malignant mesothelioma is a rare and aggressive cancer that arises from the mesothelium, a protective lining that covers many internal organs, including the lungs, heart, and abdomen. It is most commonly associated with exposure to asbestos, a fibrous mineral previously used in various industrial applications. While there are several histological subtypes of mesothelioma, the epithelioid type is the most prevalent, accounting for roughly 60% of all cases.

What is Malignant Epithelioid Mesothelioma?

Epithelioid mesothelioma is characterized by cells that resemble epithelial cells, which are the cells that line the surfaces of organs and cavities. These cells tend to grow in clusters and often form gland-like structures. Under a microscope, they appear as tightly packed cells with abundant cytoplasm, distinct cell borders, and often a central nucleus. The epithelioid subtype is considered to have a relatively better prognosis compared to other mesothelioma subtypes, like sarcomatoid mesothelioma, due to its slower growth rate and potential responsiveness to certain treatments.

Causes and Risk Factors

The primary cause of malignant mesothelioma, including the epithelioid type, is exposure to asbestos fibers. Asbestos was widely used in various industries for its heat-resistant and insulating properties, but its carcinogenic nature has led to its widespread ban in many countries.

Exposure to asbestos can occur through:

Occupational exposure: Workers in industries such as shipbuilding, construction, mining, and manufacturing have historically faced high risks due to asbestos use in these sectors.
Environmental exposure: Exposure can also occur through living near asbestos-containing buildings, or from secondary exposure through contaminated clothing brought home by workers.
Consumer products: Asbestos was once used in consumer products like brake pads, roofing materials, and floor tiles.

While asbestos is the main culprit, other factors can also contribute to mesothelioma development, including:

Genetic predisposition: Certain genetic mutations have been linked to an increased risk of mesothelioma.
Exposure to other carcinogens: Exposure to certain chemicals, like silica and radiation, can also increase the risk of mesothelioma.
Smoking: Smoking is a known risk factor for many types of cancer, including mesothelioma.

Symptoms

Symptoms of epithelioid mesothelioma can vary depending on the location of the tumor, the stage of the disease, and individual factors. However, some common symptoms include:

Shortness of breath: This is often a prominent symptom, especially in cases of pleural mesothelioma .
Chest pain: Pain may be sharp or dull and can worsen with deep breaths or coughing.
Cough: A persistent cough may occur, sometimes accompanied by blood.
Weight loss: Unexplained weight loss is a common symptom of cancer, including mesothelioma.
Fatigue: Feeling tired and weak is a common symptom of mesothelioma.
Swelling in the abdomen: This may occur in cases of peritoneal mesothelioma, which affects the lining of the abdominal cavity.

It's important to note that these symptoms can also be caused by other conditions, so seeking medical attention is crucial for proper diagnosis.

Diagnosis

Diagnosing malignant mesothelioma, including the epithelioid type, can be challenging, especially in its early stages. It often involves a combination of medical history, physical examination, and imaging tests. The diagnostic process typically involves the following steps:

Medical history and physical examination: Your doctor will ask about your medical history, including past asbestos exposure, and perform a physical examination to assess for any signs of disease.
Imaging tests: Imaging tests, such as chest X-ray, computed tomography scan, and magnetic resonance imaging , can help visualize the tumor and determine its location and size.
Biopsy: A biopsy is considered the gold standard for diagnosing mesothelioma. This involves taking a small sample of tissue from the tumor to be examined under a microscope by a pathologist.
Cytology: This involves examining fluid samples from the chest or abdomen for the presence of mesothelioma cells.

Staging

Once mesothelioma is diagnosed, it is staged to determine the extent of the disease. Staging helps guide treatment decisions and predict prognosis. The most commonly used staging system for mesothelioma is the TNM staging system. T refers to the size and location of the tumor, N refers to the involvement of lymph nodes, and M refers to the presence of metastasis .

There are four stages of mesothelioma:

Stage I: The tumor is confined to the mesothelium and has not spread to nearby tissues or lymph nodes.
Stage II: The tumor has grown larger and may have spread to nearby tissues, but has not reached lymph nodes.
Stage III: The tumor has spread to lymph nodes.
Stage IV: The tumor has spread to distant organs or tissues.

Treatment

Treatment for malignant mesothelioma, including the epithelioid type, depends on factors such as the stage of the disease, the patient's overall health, and their preferences. Treatment options may include:

Surgery: Surgery may be an option for early-stage mesothelioma to remove the tumor and potentially improve survival. However, surgery is not always feasible, especially for advanced-stage disease.
Chemotherapy: Chemotherapy is a systemic treatment that uses drugs to kill cancer cells. It may be used alone or in combination with other treatments to shrink the tumor or slow its growth.
Radiation therapy: Radiation therapy uses high-energy rays to kill cancer cells. It may be used to shrink the tumor or relieve pain.
Immunotherapy: Immunotherapy helps the body's immune system fight cancer cells. It may be used alone or in combination with other treatments.
Palliative care: Palliative care focuses on relieving symptoms and improving quality of life for patients with advanced disease.

Prognosis

The prognosis for patients with malignant mesothelioma, including the epithelioid type, varies depending on factors such as the stage of the disease, the patient's overall health, and their response to treatment. While epithelioid mesothelioma typically has a better prognosis than other subtypes, it remains a serious cancer with limited treatment options and a relatively poor overall survival rate.

Prevention

The most effective way to prevent malignant mesothelioma is to avoid exposure to asbestos. This can be achieved by:

Avoiding workplaces with asbestos exposure: If you work in a job that involves asbestos, take necessary precautions to minimize exposure. This includes wearing protective clothing, using respirators, and following safety protocols.
Protecting yourself from environmental exposure: If you live in an area with asbestos-containing buildings, take steps to minimize exposure, such as keeping windows closed, using air purifiers, and avoiding areas that may have asbestos dust.
Seeking regular medical checkups: If you have a history of asbestos exposure, it's crucial to seek regular medical checkups to detect mesothelioma early, when it is more treatable.

Research and Future Directions

Research into mesothelioma is ongoing, with a focus on developing new and more effective treatments. Ongoing research areas include:

New chemotherapy drugs: Researchers are investigating new chemotherapy drugs that are more effective against mesothelioma cells.
Targeted therapies: Targeted therapies aim to specifically target the mechanisms that drive the growth of mesothelioma cells.
Immunotherapy: Immunotherapy research focuses on developing new approaches to enhance the body's immune response against mesothelioma.
Combination therapies: Combining different treatments, such as chemotherapy and immunotherapy, may offer better outcomes for patients with mesothelioma.

Conclusion

Malignant mesothelioma is a complex and challenging cancer that requires a comprehensive understanding of its causes, diagnosis, treatment, and prognosis. Research into this rare disease is crucial for improving treatment outcomes and offering hope to patients and their families.

Disclaimer: This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for diagnosis, treatment, and management of any medical condition.

Mesothelioma Asbestos Talc Cancer